Nexion Biosensor Platform®


Continuous Biochemical Intelligence


Bio Nexa's Technology: Where Semiconductors Meet Human Biology



Enabling Resilient U.S. Health and Biodefense Infrastructure


Bio Nexa is developing a CMOS-compatible semiconductor sensing platform designed to enable secure, scalable, and domestically manufacturer biosensing systems. The platform integrates semiconductor device architectures, advanced signal processing, and artificial intelligence to support continuous biochemical signal detection and analysis across healthcare, research, and national resilience applications.


The sensing layer is built on CMOS-compatible semiconductor device arrays engineered to detect biochemical signals through electrically measurable interactions at functionalized sensor surfaces. These devices integrate analog front-end circuitry, on-chip signal conditioning, and high-resolution data acquisition to enable sensitive detection of molecular biomarkers in real time. By leveraging mature CMOS manufacturing processes, MEMS sensors and the architecture is designed to support scalable fabrication, reliable performance, and seamless integration with downstream signal processing and analytics systems.


The Bio Nexa platform is designed to operate within existing semiconductor manufacturing ecosystems while enabling new sensing capabilities that support next-generation biomedical monitoring, decentralized clinical research, and public health infrastructure systems.


By integrating edge computing and secure cloud infrastructure, each chip processes and transmits data with unmatched accuracy, privacy, and speed. This is not incremental innovation; it’s a new class of real-time molecular intelligence designed for the next era of bio defense and clinical research.


Built on domestic semiconductor manufacturing, our platform advances U.S. technological independence under the CHIPS and Science Act—bridging the gap between human health and hardware innovation.


Revolutionizing Clinical Monitoring Through Silicon-Based Biosensor Technology In Critical and Standard Health Care Environments



At Bio Nexa, we are redefining how United States bio defense in critical environments, clinical trials, and chronic-care studies collect and interpret patient data. Our breakthrough silicon biosensor platform continuously monitors key biomarkers in real time, empowering researchers, and clinicians to make faster, data-driven decisions.


01

Nexion Bio Sensors®


CMOS Biosensor Device

Chiplet Based

02

Analog Front-End & Signal Conditioning

03

On-Chip Encrypted Data Acquisition
 
Edge Signal Processing / AI

04

Biodefense & Clinical Research Applications

  • Sweat-based biosensor
  • Core body temp (fever detection)
  • Oxygen, heart rate variability
  • Neurological signals (future)

Strong for pandemic early detection

01

Vision

To establish a new standard in healthcare through continuous, real-time biosensing, enabling early detection, rapid response, and resilient national health infrastructure powered by semiconductor-based technologies.

02

Platform

The Nexion Biosensor Platform® integrates CMOS-compatible MEMS sensors, semiconductor chips, embedded telemetry, and wireless communication into wearable and intraoral devices, enabling scalable, high-fidelity biomarker monitoring across clinical and field environments.

03

  • Cortisol, Glucose, Infection markers
  • Drug adherence monitoring
  • Early disease detection

Our technology combines miniaturized semiconductor architectures with biocompatible form factors, allowing sensors to operate directly within the human body interface. This enables continuous, label-free detection of biochemical signals not achievable with traditional diagnostics.

04

Dedication

Designed for clinical research, bio-defense, and public health applications, the platform supports decentralized monitoring, early threat detection, and improved trial efficiency, aligning with U.S. priorities for secure domestic manufacturing and healthcare resilience.

Monitoring The Worlds Health

Powering Continuous Biosensing for Early Detection

Bio Defense and National Health Resilience

01

Continuous, real-time biosensing enables early detection of physiological biochemical changes at the point of care.

02

CMOS-compatible, MEMS sensors, dissolvable micro needle patch,integrate semiconductor intelligence directly into wearable and biocompatible devices.

03

Embedded telemetry and wireless systems deliver encrypted/secure, high-fidelity biomarker data in real time.

04

Designed for clinical, bio-defense, and public health use, the platform strengthens national health resilience and response capabilities.

OUR MISSION

Secure U.S. Manufactured Biosensing Platforms


Bio Nexa develops CMOS-compatible, MEMS-enabled biosensing platform designed for secure U.S. manufacturing and deployment across healthcare and biodefense environments.

  • Real-time pathogen and biomarker detection
  • Scalable semiconductor-based manufacturing
  • Secure, domestically produced sensing infrastructure
  • Built for national health security and resilience


Our Phase I, II, & III, R&D effort,

focuses on:

Phase 1: Architecture Validation and Process Alignment

(0–12 months)

Finalize platform architecture using conservation design rules.

Validate packaging, test and repeatability

Establish baseline yield and reliability metrics  




Phase 2: Prototype Fabrication and Packaging

(12–24 months)

Fabricate prototypes using trusted U.S. manufacturing flows

Validate packaging, test, and repeatability


Establish baseline yield and reliability metrics


Phase 3: Scaling and Transition Readiness

(24–36 months)

Refine architecture for scalability and reuse
•Prepare documentation supporting process transfer and adoption
•Demonstrate manufacturability rather than one-off device performance




Platform


Architecture



Platform Architecture


The Bio Nexa platform combines multiple technical layers to create a modular, reusable, chiplet-based biosensing and biosurveillance architecture designed for scalable deployment across healthcare, research, and national biodefense systems.


Semiconductor Sensing Layer (“Wet” Biosensing Layer)


CMOS-compatible MEMS device architectures form the biological sensing interface, enabling continuous detection of low-concentration biochemical signals through electrically measurable interactions at functionalized sensor surfaces.

This “wet” biosensing layer supports real-time detection of critical biomarkers, including cytokines, hormones, and sepsis indicators, while remaining compatible with standard semiconductor fabrication environments.


Chiplet-Based Semiconductor Layer (“Dry” Electronics Layer)


The platform incorporates a modular, reusable, and interoperable chiplet-based architecture that separates sensing from computation and communication functions.

This “dry” chiplet layer includes:

  • Power Chiplets: Ultra-low power management and energy optimization for continuous operation
  • Processing Chiplets: On-chip signal conditioning, edge analytics, and data interpretation
  • Secure Communication Chiplets: Encrypted transmission of sensitive biomedical data

This architecture enables scalable system integration, component reuse, and rapid reconfiguration across diverse biosensing applications.


Biocompatible Encapsulation & Selective Exposure Layer


A biocompatible encapsulation system provides hermetic sealing of semiconductor electronics while enabling controlled biological interaction at the sensing interface.

This layer supports:

  • Long-term wearability
  • Selective exposure membranes for fluid interaction
  • Protection of sensitive electronic components

This is critical for reliable operation in clinical, field, and biodefense environments.


Signal Processing and Edge Intelligence


Advanced signal processing frameworks transform raw biochemical signals into interpretable data streams in real time.

Integrated artificial intelligence and machine learning models support:

  • Signal classification
  • Anomaly detection
  • Adaptive interpretation of dynamic biological signals

These capabilities enable intelligent sensing systems operating in complex real-world environments.

Secure Data Infrastructure


The platform incorporates secure, encrypted data architectures designed to support protected biomedical data environments.

This enables:

  • Trusted data transmission
  • Integration with clinical and public health systems
  • Secure biosurveillance across distributed networks


Modular Platform Design


The Bio Nexa platform is designed as a modular, chiplet-enabled system architecture supporting multiple sensing modalities and deployment environments.

This enables integration across:

  • Wearable and minimally invasive devices
  • Clinical and research instrumentation
  • Distributed monitoring and biosurveillance systems


CMOS-Compatible Semiconductor Manufacturing


A core design principle of the platform is compatibility with existing semiconductor fabrication processes.

By leveraging mature CMOS manufacturing environments, the platform:

  • Reduces technical risk
  • Enables scalable production
  • Supports domestic semiconductor fabrication under U.S. infrastructure initiatives


Applications


The platform supports a range of mission-critical applications, including:

  • Continuous biosurveillance and biochemical monitoring systems
  • Early detection of sepsis and infectious disease biomarkers
  • Decentralized and remote clinical trial infrastructure
  • Public health and population-level monitoring networks
  • Environmental and biological threat detection systems
  • Secure healthcare and biomedical data analytics platforms


Supporting the Domestic Semiconductor Ecosystem


By designing biosensing technologies compatible with existing semiconductor manufacturing environments, Bio Nexa supports the expansion of domestic semiconductor capabilities while enabling new application domains in healthcare and national security.


Research and Development Focus


Bio Nexa’s research efforts focus on advancing:

  • CMOS-compatible biosensing device architectures
  • Chiplet-based semiconductor integration
  • Wet/dry system integration for biosensing platforms
  • Biocompatible encapsulation and packaging technologies
  • AI-enabled signal processing frameworks
  • Secure biomedical data infrastructures
  • Scalable biosurveillance systems for distributed environments
  • Semiconductor manufacturing capacity and workforce development


Through this work, Bio Nexa demonstrates how modular, chiplet-based semiconductor systems can enable next-generation biosensing platforms, supporting resilient health infrastructure, real-time biosurveillance, and national biodefense readiness.